Diego Dibitetto

My primary research interest is to understand how cancer cells utilize Homologous Recombination (HR) to maintain a stable genome. In particular, I am combining genetic, biochemical and phosphoproteomics tools to study how the ATR signaling controls HR and how manipulating ATR signaling affects HR capacity in cancer.